These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6802410)

  • 1. Nuclear magnetic resonance studies of forearm muscle in Duchenne dystrophy.
    Newman RJ; Bore PJ; Chan L; Gadian DG; Styles P; Taylor D; Radda GK
    Br Med J (Clin Res Ed); 1982 Apr; 284(6322):1072-4. PubMed ID: 6802410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in vivo study of muscle phosphate metabolism in Becker's dystrophy by 31P NMR spectroscopy.
    Newman RJ
    Metabolism; 1985 Aug; 34(8):737-40. PubMed ID: 4021805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 31P NMR studies in Duchenne muscular dystrophy: age-related metabolic changes.
    Younkin DP; Berman P; Sladky J; Chee C; Bank W; Chance B
    Neurology; 1987 Jan; 37(1):165-9. PubMed ID: 3796830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The functional staging of Duchenne muscular dystrophy using in vivo 31P MR spectroscopy.
    Ikehira H; Nishikawa S; Matsumura K; Hasegawa T; Arimizu N; Tateno Y
    Radiat Med; 1995; 13(2):63-5. PubMed ID: 7667509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain abnormalities in Duchenne muscular dystrophy: phosphorus-31 magnetic resonance spectroscopy and neuropsychological study.
    Tracey I; Scott RB; Thompson CH; Dunn JF; Barnes PR; Styles P; Kemp GJ; Rae CD; Pike M; Radda GK
    Lancet; 1995 May; 345(8960):1260-4. PubMed ID: 7746055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular energetics of dystrophic muscle.
    Kemp GJ; Taylor DJ; Dunn JF; Frostick SP; Radda GK
    J Neurol Sci; 1993 Jun; 116(2):201-6. PubMed ID: 8393092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human leg neuromuscular diseases: P-31 MR spectroscopy.
    Bárány M; Siegel IM; Venkatasubramanian PN; Mok E; Wilbur AC
    Radiology; 1989 Aug; 172(2):503-8. PubMed ID: 2748832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscle energy metabolism in Duchenne dystrophy studied by 31P-NMR: controlled trials show no effect of allopurinol or ribose.
    Griffiths RD; Cady EB; Edwards RH; Wilkie DR
    Muscle Nerve; 1985; 8(9):760-7. PubMed ID: 3935926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duchenne muscular dystrophy: adenosine triphosphate and creatine phosphate content in muscle.
    Samaha FJ; Davis B; Nagy B
    Neurology; 1981 Jul; 31(7):916-9. PubMed ID: 7195521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative NMRI and NMRS identify augmented disease progression after loss of ambulation in forearms of boys with Duchenne muscular dystrophy.
    Wary C; Azzabou N; Giraudeau C; Le Louër J; Montus M; Voit T; Servais L; Carlier P
    NMR Biomed; 2015 Sep; 28(9):1150-62. PubMed ID: 26215733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of human mitochondrial myopathies by phosphorus magnetic resonance spectroscopy.
    Arnold DL; Taylor DJ; Radda GK
    Ann Neurol; 1985 Aug; 18(2):189-96. PubMed ID: 4037759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of phosphate metabolites, the intracellular pH, and the state of adenosine triphosphate in intact muscle by phosphorus nuclear magnetic resonance.
    Burt CT; Glonek T; Bárány M
    J Biol Chem; 1976 May; 251(9):2584-91. PubMed ID: 4452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canine X-linked muscular dystrophy studied with in vivo phosphorus magnetic resonance spectroscopy.
    McCully K; Giger U; Argov Z; Valentine B; Cooper B; Chance B; Bank W
    Muscle Nerve; 1991 Nov; 14(11):1091-8. PubMed ID: 1745283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exercise metabolism in Duchenne muscular dystrophy: a biochemical and [31P]-nuclear magnetic resonance study of mdx mice.
    Dunn JF; Tracey I; Radda GK
    Proc Biol Sci; 1993 Mar; 251(1332):201-6. PubMed ID: 8097327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated phosphodiester and T
    Hooijmans MT; Niks EH; Burakiewicz J; Verschuuren JJ; Webb AG; Kan HE
    NMR Biomed; 2017 Jan; 30(1):. PubMed ID: 27859827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo muscle magnetic resonance spectroscopy in the clinical investigation of mitochondrial disease.
    Matthews PM; Allaire C; Shoubridge EA; Karpati G; Carpenter S; Arnold DL
    Neurology; 1991 Jan; 41(1):114-20. PubMed ID: 1985275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-invasive evaluation of malignant hyperthermia susceptibility with phosphorus nuclear magnetic resonance spectroscopy.
    Olgin J; Argov Z; Rosenberg H; Tuchler M; Chance B
    Anesthesiology; 1988 Apr; 68(4):507-13. PubMed ID: 3354887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Forearm metabolic asymmetry detected by 31P-NMR during submaximal exercise.
    Minotti JR; Johnson EC; Hudson TL; Sibbitt RR; Wise LE; Fukushima E; Icenogle MV
    J Appl Physiol (1985); 1989 Jul; 67(1):324-9. PubMed ID: 2759961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Forearm P-31 nuclear magnetic resonance spectroscopy studies in oculopharyngeal muscular dystrophy.
    Zochodne DW; Koopman WJ; Witt NJ; Thompson T; Driedger AA; Gravelle D; Bolton CF
    Can J Neurol Sci; 1992 May; 19(2):174-9. PubMed ID: 1623442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 31P-NMR study of muscle exercise metabolism in mdx mice: evidence for abnormal pH regulation.
    Dunn JF; Tracey I; Radda GK
    J Neurol Sci; 1992 Nov; 113(1):108-13. PubMed ID: 1469448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.